REL: Difference between revisions

Jump to navigation Jump to search
(Reverted 1 good faith edit by Markgomez using STiki)
 
imported>QYYZ
mNo edit summary
 
Line 1: Line 1:
{{see also|REL (disambiguation)}}
{{for other uses|REL (disambiguation)}}
{{Infobox_gene}}
{{Infobox_gene}}
The '''proto-oncogene c-Rel''' is a [[protein]] that in humans is encoded by the ''REL'' [[gene]].<ref name="pmid1577270">{{cite journal | vauthors = Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA | title = I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity | journal = Genes Dev | volume = 6 | issue = 5 | pages = 745–60 |date=Jun 1992 | pmid = 1577270 | pmc = | doi =10.1101/gad.6.5.745 }}</ref>  The c-Rel protein is a member of the [[NF-κB]] family of [[transcription factor]]s and contains a Rel homology domain ([[Rel homology domain|RHD]]) at its [[N-terminus]] and two [[C-terminal]] transactivation domains. c-Rel has an important role in [[B cell|B-cell]] survival and proliferation.  The REL gene is amplified or mutated in several human [[B-cell lymphoma]]s, including [[diffuse large B-cell lymphoma]] and [[Hodgkin's lymphoma]].<ref name="pmid14755244">{{cite journal | vauthors = Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT | title = The c-Rel transcription factor and B-cell proliferation: a deal with the devil | journal = Oncogene | volume = 23 | issue = 13 | pages = 2275–86 |date=March 2004 | pmid = 14755244 | doi = 10.1038/sj.onc.1207410 }}</ref>
The '''proto-oncogene c-Rel''' is a [[protein]] that in humans is encoded by the ''REL'' [[gene]].<ref name="pmid1577270">{{cite journal | vauthors = Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA | title = I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity | journal = Genes Dev | volume = 6 | issue = 5 | pages = 745–60 |date=Jun 1992 | pmid = 1577270 | pmc = | doi =10.1101/gad.6.5.745 }}</ref>  The c-Rel protein is a member of the [[NF-κB]] family of [[transcription factor]]s and contains a Rel homology domain ([[Rel homology domain|RHD]]) at its [[N-terminus]] and two [[C-terminal]] transactivation domains. c-Rel has an important role in [[B cell|B-cell]] survival and proliferation.  The REL gene is amplified or mutated in several human [[B-cell lymphoma]]s, including [[diffuse large B-cell lymphoma]] and [[Hodgkin's lymphoma]].<ref name="pmid14755244">{{cite journal | vauthors = Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT | title = The c-Rel transcription factor and B-cell proliferation: a deal with the devil | journal = Oncogene | volume = 23 | issue = 13 | pages = 2275–86 |date=March 2004 | pmid = 14755244 | doi = 10.1038/sj.onc.1207410 }}</ref>

Latest revision as of 21:36, 9 May 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

The proto-oncogene c-Rel is a protein that in humans is encoded by the REL gene.[1] The c-Rel protein is a member of the NF-κB family of transcription factors and contains a Rel homology domain (RHD) at its N-terminus and two C-terminal transactivation domains. c-Rel has an important role in B-cell survival and proliferation. The REL gene is amplified or mutated in several human B-cell lymphomas, including diffuse large B-cell lymphoma and Hodgkin's lymphoma.[2]

References

  1. Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA (Jun 1992). "I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity". Genes Dev. 6 (5): 745–60. doi:10.1101/gad.6.5.745. PMID 1577270.
  2. Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT (March 2004). "The c-Rel transcription factor and B-cell proliferation: a deal with the devil". Oncogene. 23 (13): 2275–86. doi:10.1038/sj.onc.1207410. PMID 14755244.

Further reading

External links